# Relmada Therapeutics, Inc.: Form 8-K, filed May 30, 2024

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2024-05-30
- Accepted by EDGAR: May 30, 2024, 16:05 ET
- Period: 2024-05-24
- Accession: 0001213900-24-047968
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390024047968/ea0207126-8k_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390024047968/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390024047968/ea0207126-8k_relmada.htm

Filed May 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-047968. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
